文献速递脊柱关节炎

白介素-17对银屑病关节炎风险的因果效应:一项孟德尔随机化研究

The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究利用全基因组关联研究(GWAS)汇总数据,以健康个体中影响TNF-α、IL-12p70和IL-17生理浓度的位点为暴露,以UK Biobank中银屑病关节炎(PsA)的GWAS为结局,进行两样本孟德尔随机化分析。逆方差加权法提示遗传预测的较高IL-17水平与PsA风险降低相关(β=-0.00186每等位基因,P=0.002),而TNF-α和IL-12p70未见因果效应。

要点

  • 遗传预测的较高生理性IL-17水平与银屑病关节炎风险降低相关。
  • TNF-α和IL-12p70水平与银屑病关节炎风险无因果关联证据。
  • rs117556572的C等位基因与银屑病关节炎风险稳健相关。

核心结论

  • 遗传变异所致的较高生理性IL-17水平与银屑病关节炎风险降低相关,提供初步证据。

研究设计与样本

  • 采用逆方差加权法(IVW)、加权中位数法和MR-Egger回归法进行分析,并进行了敏感性分析和MR-Egger回归分析以评估异质性和多效性。

主要发现

  • IVW法显示IL-17水平升高与PsA风险存在因果关联(β=-0.00186每等位基因,s.e.=0.00043,P=0.002)。
  • 加权中位数法结果一致(β=-0.00145每等位基因,s.e.=0.00059,P=0.014),MR-Egger法提示非显著关联(β=-0.00133每等位基因,s.e.=0.00087,P=0.087)。
  • 单SNP MR分析显示rs117556572的C等位基因与PsA风险稳健相关(β=0.00210,s.e.=0.00069,P=0.002)。
  • 未观察到TNF-α、IL-12p70或IL-17水平降低与PsA风险之间的因果效应证据。

临床怎么用

  • 遗传预测的较高生理性IL-17水平与银屑病关节炎风险降低相关,提示IL-17通路在PsA发病中可能具有复杂作用,但尚不能直接指导临床用药。

局限性

  • 研究结果为初步证据,需进一步验证。
  • MR-Egger法未显示显著关联,提示结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine causal associations between genetically predicted TNF-α, IL-12p70 and IL-17 levels and risk of PsA. METHODS: The publicly available summary-level findings from genome-wide association studies (GWAS) was used to identify loci influencing normal physiological concentrations of TNF-α, IL-12p70 and IL-17 (n = 8293) among healthy individuals as exposure and a GWAS for PsA from the UK Biobank (PsA = 900, control = 462 033) as the outcome. A two-sample Mendelian randomization (MR) analysis was performed using the inverse-variance weighted (IVW), weighted median and MR-Egger regression methods. Sensitivity analysis and MR-Egger regression analysis were performed to evaluate the heterogeneity and pleiotropic effects of each variant. RESULTS: Single-nucleotide polymorphisms (SNPs) at genome-wide significance from GWASs on TNF-α, IL-12p70 and IL-17 were identified as the instrumental variables. The IVW method indicated a causal association between increased IL-17 level and risk of PsA (β = -0.00186 per allele, s.e. = 0.00043, P = 0.002). Results were consistent in the weighted median method (β = -0.00145 per allele, s.e. = 0.00059, P = 0.014) although the MR-Egger method suggested a non-significant association (β = -0.00133 per allele, s.e. = 0.00087; P = 0.087). Single SNP MR results revealed that the C allele of rs117556572 was robustly associated with risk of PsA (β = 0.00210, s.e. = 0.00069, P = 0.002). However, no evidence for a causal effect was observed between TNF-α, IL-12p70, decreased IL-17 levels and risk of PsA. CONCLUSION: Our findings provide preliminary evidence that genetic variants predisposing to higher physiological IL-17 level are associated with decreased risk of PsA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wu D, Wong P, Lam SHM, et al. The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study. Rheumatology (Oxford). 2021. PMID: 33188428. doi:10.1093/rheumatology/keaa629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。